Newer Drug Seems Better at Controlling Lupus Kidney Complication

Serious adverse events less likely with mycophenolate mofetil, too, study finds

A newer immune-suppressing drug called mycophenolate mofetil (CellCept) is better at controlling a serious kidney complication from lupus than another commonly used therapy, a new study suggests.

Full story | New England Journal of Medicine study


Comments are closed.